Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Clozapine is an antipsychotic. This 24-week study will evaluate the safety and efficacy of clozapine in patients with treatment-resistant schizophrenia.
Age
18–64
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed as schizophrenia
Not responded to at least two atypical antipshychotics launched in Japan
